NTLA CapEx to Revenue

Intellia Therapeutics Inc · CapEx to Revenue

NTLA logo

NTLA CapEx to Revenue

Current (TTM)3.43%
NTLA CapEx/Revenue (0.00% → 3.43%)
High-resolution chart · PNG

NTLA capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Intellia Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
8.5384%
9.9832%
38.5527%
112.0278%
38.5926%
6.1817%
15.7622%
20.8911%
38.6377%
37.4113%
42.2568%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.